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Abstract  26 
Extracts with prebiotic activity or bioactive compounds from natural sources such 27 
as seaweeds or mushrooms, combining a broad spectrum of biological properties, 28 
may offer great potential for their use as functional ingredients enabling intestinal 29 
microbiota modulation. In this context, selected enzymatic extracts from 30 
Sargassum muticum, Osmundea pinnatiﬁda and Pholiota nameko were evaluated 31 
in vitro. Faecal fermentations were conducted anaerobically under controlled 32 
temperature and pH over 24 h. Enzymatic extracts of Ph. nameko and of O. 33 
pinnatiﬁda at 1% (w/v), lead to increases in Biﬁdobacterium spp. after 6 h of 34 
fermentation in comparison to negative control, suggesting a stimulatory effect. 35 
No signiﬁcant changes over 24 h were observed of Lactobacillus spp. In 36 
particular, the Ph. nameko extract obtained with Flavourzyme not only stimulated 37 
growth and/or activity of Biﬁdobacterium spp. but also led to a decrease of 38 
Clostridium histolyticum group upon 24 h, thus potentially beneﬁting colonic 39 
health. Higher percentages of this extract (2 and 3%) impaired a C. histolyticum 40 
reduction conﬁrming this selective action and prebiotic potential. Differences in 41 
short chain fatty acids (SCFA) and lactic acid production between the four extracts 42 
may indicate a potential relationship between their physico-chemical properties, 43 
which differ in composition and structures, and modulation of gut bacterial 44 
species.  45 
Keywords: Seaweeds, mushrooms, enzymatic extracts, fluorescence in situ 46 
hybridization (FISH), prebiotic activity 47 
 48 
 49 
 50 
  
 
 
1. Introduction 51 
Edible seaweeds and mushrooms are an excellent source of bioactive 52 
compounds (Pádua, Rocha, Gargiulo, & Ramos, 2015; Ruthes, Smiderle, & 53 
Iacomini, 2016) and therefore research into the biological potential of enzymatic 54 
extracts of seaweeds S. muticum and O. pinnatifida and of mushroom Ph. 55 
nameko to be explored within the functional food perspective, were selected for in 56 
vitro fermentation study to consolidate their prebiotic potential (Rodrigues et al., 57 
2015,2016).  58 
Prebiotics are defined as substrates that improve the host health by selectively 59 
stimulating the growth and/or metabolic activity of one or a limited number of 60 
beneficial bacteria in the colon (Roberfroid et al., 2010). The potential prebiotic 61 
effect of the selected extracts has been evaluated by comparison with 62 
fructoligosaccharides (FOS), the gold standard in comparison studies, using pure 63 
cultures (Lactobacillus acidophilus La5; Bifidobacterium animalis BB12) 64 
(Rodrigues et al., 2015,2016). The human gastrointestinal tract represents a 65 
complex ecosystem where the available nutrients and the diverse microbiota will 66 
influence changes within the community (Roberfroid et al., 2010). Hence, to 67 
assess the possible importance that colonic catabolism of these extracts may 68 
have on human gut microbiota, in vitro batch culture fermentation experiments 69 
conducted with faecal inoculum from healthy volunteers, are in order to observe 70 
changes in the main bacterial groups present within (Eid et al., 2014; Sánchez-71 
Patán et al., 2012). The human colon is considered the most metabolically active 72 
site in the human body with over 1000 species of microorganisms reaching up to 73 
1012-1013 bacteria per gram dry weight (Roberfroid et al., 2010). To study this 74 
diverse community pH controlled, anaerobic faecal batch cultures enable 75 
  
 
 
assessment of the fermentability of substrates in the intestinal lumen, whilst 76 
simulating the conditions in the human distal colon (Bergillos-Meca, Costabile, 77 
Walton, Moreno-Montoro, Ruiz-Bravo, & Ruiz-López, 2015). A growing body of 78 
evidence suggests that the gut microbiota impacts on a wide range of host 79 
metabolic pathways, barrier function and immune modulatory function influencing 80 
the prevention and risk of a wide range of diseases, including inflammatory bowel 81 
disease, diarrhoea and colorectal cancer. Much of this impact is mediated through 82 
diet and the consumption of specific health-related foods, justifying the constant 83 
need to modulate diet or identify compounds that can positively modify the gut 84 
microbiota (Gibson, Scott, Rastall, & Tuohy, 2010). 85 
Research has been focused on ‘prebiotics’, and in particular the ability of certain 86 
types of dietary fibre, especially indigestible oligosaccharides, to stimulate the 87 
growth of and/or activity of beneficial gut bacteria such as bifidobacteria and 88 
lactobacilli while retarding the development of C. histolyticum, leading to a 89 
concomitant positive effect on colonic health (Gibson et al., 2010; Aida, Shuhaimi, 90 
Yazid & Maaruf, 2009). Better understanding of the benefits of prebiotics has 91 
urged a need to search for and develop new and alternative sources of prebiotics. 92 
According to Zaporozhets et al. (2014), the prebiotic activity of extracts or of 93 
polysaccharides from marine seaweeds, combined with a broad spectrum of 94 
biological properties, evidences great potential for their use as functional nutrition 95 
ingredients enabling modulation of intestinal microbiota and of gastrointestinal 96 
tract (GIT) inflammation as well as normalization of the immune system. Therefore 97 
the main objective in this study was to evaluate the potential of the digested 98 
(closely simulating physiological conditions) seaweed and mushroom extracts 99 
containing different polysaccharide and oligosaccharide structures on gut 100 
  
 
 
microbial ecology. To our best knowledge there are no studies regarding the 101 
impact of water-based enzyme-assisted extracts for seaweeds S. muticum, O. 102 
pinnatifida or mushroom Ph. nameko on gut microbial ecology confirm and 103 
consolidate the biological potential of these selected extracts, for their application 104 
as functional food and bioactive ingredient sources. 105 
 106 
2. Material and methods 107 
2.1. Selected seaweeds and mushrooms extracts 108 
In this study water-based enzyme-assisted extracts from two seaweeds and one 109 
mushroom were selected following demonstration of potential prebiotic effect with 110 
pure cultures (Rodrigues et al., 2015,2016). Selected extracts included extracts of 111 
S. muticum obtained with Alcalase, O. pinnatifida obtained with Viscozyme and 112 
Ph. nameko obtained with Cellulase and with Flavourzyme. For each extract, 1g 113 
of dried mushroom or 2 g of dry seaweed was dispersed in 50 mL of deionised 114 
water and incubated in an agitated water bath for 10 min. After adjusting pH to 115 
specific enzyme optimum conditions (Alcalase: pH=8 – 50 ºC; Flavourzyme: 116 
pH=7.0 – 50 ºC; Cellulase: pH=4.5 – 50 ºC; Viscozyme® L: pH=4.5 – 50 ºC; All 117 
enzymes were obtained from Sigma-Aldrich), 100 mg of enzyme was added and 118 
incubated for enzymatic hydrolysis for 24h at 50 ºC. The enzymatic reaction was 119 
stopped by heating the sample at 90-100 ºC for 10 min followed by immediate 120 
cooling in an ice bath. The pH of enzymatic extracts was adjusted to pH 7.0 with 121 
1M HCl and/or NaOH and then centrifuged, filtered and freeze-dried according to 122 
Rodrigues et al. (2015, 2016). 123 
 124 
2.2. In vitro fermentation by human gut microbiota 125 
  
 
 
Samples of the selected extracts were submitted to three consecutive steps: 1) 126 
Simulated gastrointestinal digestion; 2) Faecal batch-culture fermentation and, 3) 127 
Bacterial enumeration using FISH. 128 
2.2.1. Simulated gastrointestinal digestion 129 
To simulate the digestion of the selected seaweed and mushroom extracts 130 
through the gastrointestinal tract and therefore evaluate the main effects of the 131 
digested extracts on human microbiota, samples were treated according to Mills 132 
et al. (2008), with slight alterations. Water (25 mL) was added to 10 g of 133 
lyophilized extract, and the mixture was stomached (Seward, UK) for 5 min using 134 
200 paddle-beats per min. The extract solution was then mixed with -amylase 135 
(A4551, Sigma; 3.33 mg) in CaCl2 (0.001 M, pH 7.0; 1.04 mL) and incubated at 37 136 
ºC for 30 min and at 130 rpm in a shaker. Afterwards, the pH was decreased to 137 
2.0 with 6 M HCl and pepsin (P 7000, Sigma; 0.45 g) dissolved in HCl (0.1 M; 138 
4.16 ml) was added. The sample was incubated at 37 ºC for 2 h and at 130 rpm in 139 
a shaker. After this period, the pH was increased to 7 with 6 M NaOH, and 140 
pancreatin (P 8096, Sigma; 0.93 g) and bile (B 8631, Sigma; 0.58 g) in NaHCO3 141 
(0.5 M; 20.8 mL) were added. The extract solution was then incubated at 37 ºC 142 
and at 45 rpm in a shaker for 3 h and afterwards transferred to 1 kDa molecular 143 
weight cut-off regenerated cellulose dialysis tubing (Spectra/Por® 6, Spectrum 144 
Europe, Netherlands) and dialyzed against NaCl 0.01 M at 5 ºC, to remove low 145 
molecular mass digestion products. After 15 h the NaCl dialysis fluid was changed 146 
and dialysis continued for an additional 2 h. Afterwards the digested samples 147 
were frozen at -80 ºC and lyophilized in a freeze dryer (Armfield SB4 model, 148 
Ringwood, UK). All chemicals were purchased from Sigma (St Louis, USA). 149 
2.2.2. Faecal batch-culture fermentation  150 
  
 
 
Three independent fermentation experiments were carried out. Faecal samples 151 
were obtained fresh at the premises of the Department of Food and Nutritional 152 
Sciences from 3 apparently healthy adult volunteers who ingested a normal diet, 153 
had not ingested any antibiotics for at least 6 months and were not regular 154 
consumers of pre or probiotics. Samples were collected into sterile vials and kept 155 
in an anaerobic cabinet and used within 30 min of collection. A 1/10 (w/w) dilution 156 
in phosphate buffer saline (PBS) was prepared and homogenized using a 157 
stomacher (Serward, Worthing, UK) for 2 min at 460 paddle-beats per min.  158 
Sterile stirred batch culture fermentation vessels (50 mL working volume) were set 159 
up and aseptically filled with 45 mL sterile, pre-reduced, basal medium [peptone 160 
water 2 g/L, yeast extract 2 g/L, NaCl 0.1 g/L, K2HPO4 0.04 g/L, KH2PO4 0.04 g/L, 161 
MgSO4.7H2O 0.01 g/L, CaCl2.6H2O 0.01 g/L, NaHCO3 2 g/L, Tween 80 2 mL/L 162 
(BDH, Poole, UK), Hemin 0.05 g/L, vitamin K1 10 µL/L, L-cysteine-HCl 0.5 g/L, 163 
bile salts 0.5 g/L, pH 7.0] and gassed overnight with O2-free N2 (15 mL/min) with 164 
constant agitation. All media and chemicals were purchased from Oxoid 165 
(Basingstoke, UK) and Sigma (St Louis, USA). The temperature was kept at 37 ºC 166 
and pH was controlled between 6.7 and 6.9 using an automated pH controller 167 
(Fermac 260, Electrolab, Tewkesbury, UK), which added acid or alkali (0.5 M HCl 168 
and 0.5 M NaOH) in order to mimic conditions that resemble the distal region of 169 
the human large intestine (Sánchez-Patán et al., 2012). 170 
Six stirred pH-controlled batch fermenters were run in parallel. The different 171 
digested extracts (1% w/v) were aseptically added to four vessels, the other two 172 
vessels were used as controls. For the positive control vessel 1% (w/v) of FOS 173 
(95% oligofructose, 0.5 kDa dextran with 25% -1,2 branching, 1 kDa dextran with 174 
32% -1,2 branching; Orafti®P95, Oreye, Belgium) was used. To the negative 175 
  
 
 
control vessel no source of carbon was added. The experiment was performed in 176 
triplicate, using one faecal sample given by a different donor for each run of six 177 
batch fermenters. Each vessel, with 45 mL sterile medium and digested extract, 178 
was inoculated with 5 mL of fresh faecal slurry (1/10 w/w). The batch cultures 179 
were run under anaerobic conditions for a period of 24 h, during which 5 mL 180 
samples were collected from each vessel at 0, 6, 12 and 24 h for FISH and 181 
analysis of lactic acid and short chain fatty acids (SCFA). For this latter analysis, 182 
samples were stored at -70 ºC until required.  183 
In order to assess the effect of the addition of 2 and 3% of digested extracts of O. 184 
pinnatifida obtained with Viscozyme and of Ph. nameko obtained with 185 
Flavourzyme, faecal batch-culture fermentations were repeated, in triplicate, 186 
under similar conditions but non-pH controlled and at lower volumes (10 mL) and 187 
for a period of 12 h.  188 
2.2.3. Bacterial enumeration using FISH.  189 
To assess differences in bacterial composition, FISH was used with 190 
oligonucleotide probes designed to target specific diagnostic regions of 16S rRNA 191 
based on the method described by Daims, Stoecker, & Wagner (2005). A total of 192 
6 different probes commercially synthesized and 5'-labelled with the fluorescent 193 
dye (Sigma Aldrich, St Louis, USA) were used in addition to an overall stain with 194 
4,6-diamidino-2-phenylindole (DAPI), which measures all cells by staining DNA 195 
(Harmsen, Wildeboer-Veloo, Grijpstra, Knol, Degener, & Welling, 2000a; Harmsen 196 
et al., 2000b).  197 
Samples (375 µL) obtained from each vessel and sampling time were fixed for a 198 
minimum of 4 h (4 ºC) in 1125 µL 4% (w/v) paraformaldehyde. Fixed cells were 199 
centrifuged at 13,000 g for 5 min and washed twice in 1 mL filtered sterilized PBS. 200 
  
 
 
The washed cells were re-suspended in 150 µL filtered PBS and stored in 150 µl 201 
ethanol (99%) at -20 ºC until further processing. Samples were then diluted in a 202 
suitable volume of PBS in order to obtain countable fluorescent cells in each field 203 
of view and 20 µl of the above solution was added to each well of a 6 well 204 
PTFE/poly-L-lysine coated slide (Tekdon Inc., Myakka City, USA). The samples 205 
were dried for 15 min in a drying chamber (46 ºC).  206 
To permeabilize cells for use with probes Bif164 and Lab 158 (Table 1), samples 207 
were treated with 20 L of lysozyme at room temperature for 15 min before being 208 
washed briefly in water. Slides were dehydrated, using an alcohol series (50, 80 209 
and 96% (v/v) ethanol) for 3 min in each solution. Slides were returned to the 210 
drying oven for 2 min to evaporate excess ethanol before adding the hybridization 211 
mixture to each well [(0.9 M NaCl, 0.02 M Tris/HCl (pH 8.0), 0.01% sodium 212 
dodecyl sulphate and 4.55 ng/mL probe]. For probes EUB338 I-II-III, the 213 
hybridization mixture contained formamide [(0.9 M NaCl, 0.02 M Tris/HCl (pH 8.0), 214 
35% formamide, 0.01% sodium dodecyl sulphate and 4.55 ng/mL probe]. 215 
Hybridization occurred for 4 h in a microarray hybridization incubator (Grant-216 
Boekel, Cambridge, UK). After hybridization, slides were washed in 40 mL 217 
washing buffer [0.9 M NaCl and 0.02 M Tris/HCl (pH 8.0)], and 0.005 M 218 
ethylenediaminetetraacetic acid for the EUB338 I-II-III probes with 20 µl nucleic 219 
acid stain 4’, 6-diamidino-2- phenylindole (DAPI; 50 ng/µL) for 15 min. They were 220 
then dipped in cold water for a few seconds and dried with compressed air. Five 221 
microlitres of polyvinyl alcohol mounting medium with 1,4-222 
diazabicyclo(2,2,2)octane (DABCO) was added onto each well and a cover slip 223 
was placed on each slide (20 mm, thickness No 1, VWR, Lutterworth, UK). Slides 224 
were examined by epifluorescence microscopy (Eclipse 400, Nikon, Surrey, UK) 225 
  
 
 
using the Fluor 100 lens. For each well, 15 fields with a maximum of 300 positive 226 
cells were counted. 227 
2.2.4. Lactic acid and SCFA analysis  228 
Samples were collected from each batch culture at each sampling point (0, 6, 12 229 
and 24 h) and frozen at -70 ºC until required. Samples were assessed for lactic 230 
acid and SCFA (acetic, propionic, butyric, isobutyric and isovaleric acids) using an 231 
HPLC apparatus from Merck LaChrom (Fullerton CA, USA), in a single run, based 232 
on calibration curves previously prepared with appropriate chromatographic 233 
standards; an Aminex HPX-87X cation exchange column from BioRad (Richmond 234 
CA, USA) was used for separation; the eluant was pumped at 0.8 mL/min and 235 
consisted of 13 mM H2SO4 (Merck); and detection was by UV absorbance at 220 236 
nm. Prior to analysis, samples were defrosted, centrifuged (13,000 g for 10 min at 237 
4 ºC) and filtered through a 0.22-µm membrane filter (Millipore, USA) to remove 238 
all particulate matter. 239 
2.3. Statistical Analysis 240 
A paired Student’s t test was used to test for significant differences in the bacterial 241 
group populations between extracts and controls as well as for time in vitro 242 
fermentation experiments by human gut microbiota. All data of bacterial 243 
populations (Log10 cell/mL) are expressed as average of three replicates (donors) 244 
plus or minus standard deviation, justifying the high variability reported in several 245 
cases. 246 
 247 
3. Results and discussion 248 
3.1. Modulation of intestinal microbiota by seaweed and mushroom digested 249 
extracts. 250 
  
 
 
Assessment of the prebiotic potential of bioactive compounds or extracts by in 251 
vitro fermentation with human faecal microbiota provides a cost-effective and 252 
rapid alternative to assess the fermentation and modulation capacity of different 253 
substrates on a laboratory scale comparative basis (Gullon, Gullon, Tavaria, 254 
Pintado, Gomes, Alonso, & Parajo, 2014). It is important to note that before 255 
performance of in vitro fermentations care was taken to submit each extract to 256 
simulated gastrointestinal digestion because resistance to gastric acidity and 257 
hydrolysis by mammalian enzymes are limiting factors that have to be assured in 258 
order to enable the substrate to reach the colon and be fermented by intestinal 259 
microbiota, meeting the pre-requisite for a prebiotic effect or gut modulation effect. 260 
According to Gibson et al. (2010) any dietary material that is non-digestible and 261 
enters the large intestine is a candidate prebiotic. The few studies that have 262 
evaluated the prebiotic potential of seaweed polysaccharides using in vitro 263 
fermentation (laminarin and low molecular weight polysaccharides from agar and 264 
alginate) did not undergo previous gastrointestinal digestion, hindering analysis of 265 
true effectiveness of intact compounds (Devillé, Gharbi, Dandrifosse, & Peulen, 266 
2007; Ramnani et al., 2012). During the experimental time course (0, 6, 12 and 24 267 
h) of the in vitro fermentation of the digested seaweed and mushroom extracts at 268 
1% (w/v) changes in the different bacterial populations and accumulation of lactic 269 
acid and SCFA (acetic, propionic, butyric acids) were assessed. For comparative 270 
purposes, the same experimental strategy was used with the well-established 271 
prebiotic FOS (positive control) and with medium without carbon source present 272 
(negative control) (Fig. 1).  273 
FISH was used to monitor the modifications among populations of selected 274 
bacterial species caused by the different digested S. muticum, O. pinnatifida and 275 
  
 
 
Ph. nameko enzymatic extracts added at 1%, on a comparative basis. Depending 276 
on the bacterial group different effects were observed. Both enzymatic extracts of 277 
Ph. nameko and that of seaweed O. pinnatifida obtained with Viscozyme lead to 278 
overall increases in Bifidobacterium spp. populations as compared to the negative 279 
control between 6 and 24 h of fermentation, confirming a stimulatory effect (Fig. 280 
1.a). Highest shift was observed for medium containing Ph. nameko extract 281 
obtained with Flavourzyme raising bifidobacterial counts from 8.06±0.66 Log10 282 
cell/mL at 0h to 8.49±0.06 Log10 cell/mL at 24 h (p=0.391) in comparison to the 283 
negative control at 24 h (p=0.021). Evidence for a potential prebiotic effect for 284 
pure culture of B. animalis BB12 was observed for undigested Ph. nameko 285 
enzymatic extracts (Rodrigues et al., 2016). The positive control FOS, did 286 
however induce a higher increase in bifidobacterial numbers after 24 h of 287 
fermentation; from 8.04±0.47 at 0 h to 8.98±0.13 at 24 h (p=0.017). Indeed a two-288 
fold higher increase was observed for FOS (0.94 log10) when compared to Ph. 289 
nameko extract obtained with Flavourzyme (0.43 log10). 290 
No significant lactobacilli populations changes were observed over the 24 h in 291 
comparison to the negative control for any of the four extracts tested at 1% except 292 
for FOS (Fig. 1.b). These results contrast with those reported in previous studies 293 
obtained with pure cultures of L. acidophilus La-5; significant higher values 294 
(p<0.05) of viable cells were observed for the majority of culture media enriched 295 
with seaweed water-based extracts (Rodrigues et al., 2015) and with Ph. nameko 296 
extracts (Rodrigues et al., 2016) after 24 h of incubation in comparison to growth 297 
in media with glucose or FOS. Ramnani et al. (2012) also reported absence of 298 
effect on gut lactobacilli populations by low molecular weight polysaccharides 299 
from agar and alginate seaweeds.  300 
  
 
 
The stimulation of growth and/or activity of beneficial gut bacteria such as 301 
Bifidobacterium by the digested extract of Ph. nameko obtained with Flavourzyme 302 
was associated with a decrease in numbers of the C. histolyticum after 24 h 303 
fermentation, in comparison to the negative control (Fig. 1.e). Such a change can 304 
be considered a concomitant positive effect on colonic health (Gibson et al., 2010; 305 
Aida et al., 2009). Furthermore, it can also be highlighted that although not 306 
statistically significant, the positive control FOS was associated with an increased 307 
number of cells of C. histolyticum after 12 and 24 h in comparison to the negative 308 
control (Fig. 1.e); in contrast, decreased numbers of C. histolyticum were 309 
observed in particular for the extracts of O. pinnatifida, S. muticum and Ph. 310 
nameko obtained with Flavourzyme. Although there is a clear difference in 311 
response between FOS and studied extracts, it must be mentioned that some 312 
authors have mentioned that an increase in C. histolyticum numbers may be a 313 
consequence of culture conditions rather than a specific effect mediated by the 314 
tested prebiotic compounds (Bergillos-Meca et al., 2015). Bergillos-Meca et al. 315 
(2015) reported such an increase in C. histolyticum numbers for both positive 316 
control (FOS) and for tested probiotic/prebiotic conditions which is not the case 317 
presented herein. The digested extract of S. muticum obtained with Alcalase 318 
seems to be the less promising of the tested extracts considering the absence of 319 
a positive shift for both the Bifidobacterium and lactobacilli groups and their 320 
positive influence on the Clostridium groups at 6 and 12 h (Fig 1.a,b and e).  321 
The four digested extracts at 1% led to similar increases in numbers of total 322 
bacteria after 24 h fermentation in comparison to the negative control, which y 323 
reported a slight reduction in numbers by 24 h (Fig. 1.f). Furthermore, the four 324 
digested extracts at 1%, as well as the negative and positive controls, all led to a 325 
  
 
 
decrease in numbers of the Clostridium cocoides/E. rectale group (Fig. 1.d), which 326 
is a major anaerobic population in the human gut. Statistically significant 327 
decreases (p<0.05) were observed for S. muticum extract alongside both negative 328 
and positive controls for C. cocoides/E. rectale.  329 
Bacteroides/Prevotella population (Bacteroides group) showed an increase over 330 
the 24 h of fermentation for all the four digested extracts, being statistically 331 
significant for the S. muticum extract and for both extracts of Ph. nameko in 332 
comparison to the negative control or to the positive FOS which revealed no 333 
significant shift in numbers over the 24 h fermentation period (Fig. 1c). It is known 334 
that these genera vary greatly with the nature of the diet and while studies have 335 
revealed increased proportions of Bacteroides in vegetarians (Matijasic, 336 
Obermajer, Lipoglavsek, Grabnar, Avgustin, & Rogelj, 2014), or upon ingestion of 337 
resistant starch type 4 (Martinez, Kim, Duffy, Schlegel, and Walter, 2010), further 338 
studies have detected no alterations in Bacteroides upon ingestion of formula diet 339 
containing FOS and pea fibre (Benus et al., 2010) or upon blueberry drink 340 
consumption (Vendrame, Guglielmetti, Riso, Arioli, Klimis-Zacas, & Porrini, 2011). 341 
In contrast, in a study by Vulevic, Juric, Tzortzis, & Gibson (2013), 342 
galactooligosaccharide consumption by overweight adults led to a reduction in the 343 
Bacteroides population. Although Bacteroides/Prevotella populations increased 344 
with the addition of the digested extracts to the medium it is important to correlate 345 
shift in population with the production of SCFA. Bacteroides and Prevotella 346 
genera are organisms capable of using a very wide range of substrates and are 347 
major producers of propionic acid. As may be seen from data listed in Table 2 and 348 
discussed further, propionic production is significant by 24 h fermentation, and of 349 
the same order of magnitude, for the positive control FOS and for both the Ph. 350 
  
 
 
nameko extracts, yet branched-chain fatty acids are reduced, which is concurrent 351 
with a decrease in protein fermentation and of positive influence as far as 352 
Bacteroides modulation is concerned.  353 
In order to observe if increasing concentrations of the digested enzymatic 354 
seaweeds and mushroom extracts would have a higher impact on gut microbiota 355 
modulation, similar in vitro fermentations were repeated with 2 and 3% (w/v) of 356 
extracts of O. pinnatifida obtained with Viscozyme and of Ph. nameko obtained 357 
with Flavourzyme. The selection of these two extracts was based on the best 358 
prebiotic potential selectivity effect demonstrated within each group of extracts, 359 
seaweeds and mushroom. The respective results are displayed in Figure 2. 360 
Interesting results were obtained for Bifidobacterium spp., Lactobacillus spp. and 361 
C. histolyticum group (Fig. 2.a, 2.b and 2.e), respectively; - an increase in the 362 
concentration of the digested extracts did not bring about a higher impact on 363 
Bifidobacterium spp. abundance and increases in population numbers were 364 
similar between digested extracts and the positive control FOS in comparison to 365 
the negative control which registered no alteration over 12 h fermentation; - 366 
abundance in the lactobacilli group was significantly increased with 2 and 3% 367 
digested extracts in comparison to the digested extracts at 1% fermentation (Fig. 368 
1.b) where no significant increases had been observed for the extracts; - higher 369 
increases in lactobacilli populations, although not statistically significant (p>0.05), 370 
were observed between 0 and 6h for both concentrations of Ph. nameko extracts 371 
than with FOS at 2% and at 12 h of fermentation similar numbers of cells were 372 
observed for both Ph. nameko extracts and these were higher than those 373 
obtained with FOS 2% and with the negative control; - although the experiments 374 
with 2 and 3% Ph. nameko extract started with the lowest level of C. histolyticum 375 
  
 
 
in the faecal inocula these extracts brought about the only statistical significant 376 
decreases of C. histolyticum by 12 h (p=0.0003 for 2% and p=0.028 for 3%, 377 
respectively) in comparison to 0 h and in comparison to FOS (p>0.05) and 378 
negative control (p>0.05). Numbers of C. histolyticum continued to diminish with 379 
higher percentages of Ph. nameko Flavourzyme extracts (in comparison to 1% 380 
extract) confirms their selectivity properties and prebiotic potential, although this 381 
result could be a consequence of the lower pH (non-pH controlled experiment) 382 
inhibitory effect on the microbial group, must not be overlooked. At higher 383 
percentages cross-feeding may become more predominant and selectivity could 384 
in fact be lost, yet this is not the case since C. histolyticum showed no proliferation 385 
and decreased in numbers.  386 
3.2 Lactic acid and SCFA production 387 
Lactic acid and SCFA, the main products arising from the microbial fermentation 388 
of carbohydrates, can provide energy to the colonic epithelium, modulate 389 
cholesterol and lipid metabolism, suppress pathogenic intestinal bacteria and 390 
modulate the immune system (Salazar, Prieto, Leal, Mayo, Bada-Gancedo, & 391 
Madiedo, 2009). Furthermore, they act as electron sinks of anaerobic respiration 392 
in the gut and decrease the intestinal pH, thus enhancing the bioavailability of 393 
minerals such as calcium and magnesium (Gullon et al., 2014). The concentration 394 
of acetic, propionic, butyric, isobutyric and isovaleric acids as well as lactic acid 395 
produced during 24 h fermentation of the different extracts added at 1% is shown 396 
in Table 2. Significant differences were found between donors with respect to the 397 
levels of the different SCFA, in particular with acetic and butyric acids. In some 398 
cases the SCFA were detected in only one donor, particularly for propionic, 399 
  
 
 
butyric and branched-chain fatty acids. It is estimated that 90% of SCFA are 400 
absorbed and therefore low levels may be found in faeces 401 
, SCFA production in the negative control was the lowest (14.3 mM by 24 h) in 402 
comparison with the media containing either the seaweed or the mushroom 403 
extracts. The lack of a carbohydrate may ascribe SCFA production in the negative 404 
control to protein degradation by putrefactive bacteria (Gullon et al., 2014) or to 405 
residual undigestive components within the faeces. The total SCFA 406 
concentrations achieved were highest for medium containing the positive control 407 
FOS (75.1 mM by 24 h), followed by medium added with the Ph. nameko extracts 408 
(50.9 and 50.5 mM by 24 h for Ph. nameko Flavourzyme extract and Ph. nameko 409 
Cellulase extract, respectively) and lastly by media added with O. pinnatifida 410 
Viscozyme extract (26.7 mM) and S. muticum Alcalase extract (20.0 mM by 24 h). 411 
These observations correlate well with the observed modulation by the associated 412 
extracts of SCFA producer bifidobacterial and lactobacilli bacterial populations 413 
discussed in the previous section. Importantly, most of the SCFA production 414 
occurred during the first 12 h of fermentation. Acetic and propionic acids were the 415 
main SCFA produced in all media containing any of the four extracts or FOS. 416 
Highest values for both acetic and propionic acids were observed in media 417 
containing FOS, yet importantly concentrations were also produced in media 418 
containing either of the Ph. nameko extracts. Propionic acid concentrations were 419 
highest for media containing FOS or the Ph. nameko extract obtained with 420 
Flavourzyme. These concentrations may be related to the high numbers of 421 
Bacteroides present or to the presence of specific compounds in the extracts. 422 
Broekaert, Courtin, Verbeke, Van de Wiele, Verstraete, & Delcour (2011), 423 
associated propionic acid production with the side chains found in 424 
  
 
 
xilooligosaccharides. The acetic-to-propionic ratio increased along fermentation 425 
for all substrates except for the Ph. nameko Flavourzyme extract, which 426 
registered an effective decrease between 12 and 24 h (1.1 to 0.8). Low acetic-to-427 
propionic ratios have been proposed as a positive marker for a hypolipidemic 428 
effect consequence of cholesterol biosynthesis inhibition (Salazar, Gueimonde, 429 
Hernández-Barranco, Ruas- Madiedo, & de los Reyes-Gavilán, 2008). All tested 430 
extracts led to the production of low levels of butyric acid by 24 h fermentation in 431 
comparison to the positive control FOS. In general, levels of butyric acid were 432 
either similar to those obtained by FOS, as is the case of O. pinnatifida extract 433 
(average values of 5.9 mM against 6.6 mM FOS) or ca. two-fold lower as for Ph. 434 
nameko extracts (average values of 3.0 and 2.3 mM); values reported for FOS 435 
were however quite moderate in comparison to values reported for other studies 436 
(for example 12-24 mM in Gullon et al., 2014) albeit a high variability between 437 
donors must be highlighted in this latter case. Related results were reported by 438 
Benus et al. (2010) who showed that butyric acid was reduced following the fibre-439 
supplemented diet (FOS and pea fibre). 440 
Concentrations of the branched chain fatty acids, isobutyric and isovaleric acids 441 
were either below detection limit or, in many cases, were detected in only one 442 
donor. 443 
Lactic acid production was highest when FOS was used as a substrate correlating 444 
well with the predominant Bifidobacterium/Lactobacillus populations. Lactic acid 445 
was also produced in the media containing the tested substrates during the first 6 446 
h of fermentation, in contrast to medium with FOS which achieved maximum lactic 447 
acid production by 12 h fermentation. Thereafter, lactic acid was consumed 448 
independently of the substrate in question. Consumption rate was highest in 449 
  
 
 
media containing FOS. This observation may eventually suggest a cross-feeding 450 
mechanism (Gullon et al., 2014). 451 
The differences observed in SCFA and lactic acid production for the four 452 
substrates tested tend to indicate that a relationship may exist between physico-453 
chemical properties of extracts and modulation of individual bacterial species and 454 
SCFA production in the gut. The four extracts tested displayed different 455 
composition (for example, higher content of sugars was observed in extracts 456 
obtained with Viscozyme and Cellulase) and structures (less sulphated 457 
polysaccharides in O. pinnatifida extract or presence of  and -glycosidic 458 
structures such as glucans and glucan-protein complexes in both Ph. nameko 459 
extracts) some of which may be more accessible for use (Rodrigues et al., 460 
2015,2016). The different enzymatic treatments on the different seaweed or 461 
mushroom sources lead to the release of different oligomer residues from the 462 
structural and storage polysaccharides making these susceptible to degradation. 463 
Similarly, Ramnani et al. (2012) showed that low molecular weight extracts 464 
derived from agar and alginate seaweeds were fermentable by gut microbiota 465 
leading to important increases in acetate and propionate. 466 
 467 
4. Conclusions 468 
All tested extracts had an influence on the composition of human gut microbiota, 469 
albeit to different extents. The digested Ph. nameko extract obtained with 470 
Flavourzyme was found to hinder growth of C. histolyticum and growth of 471 
members of the C. coccoides–E. rectale group, while growth of Bifidobacterium 472 
spp. was enhanced and Lactobacillus spp. remained relatively unaffected. This 473 
  
 
 
selective increase in bifidobacteria coupled to a consistent increase in total SCFA 474 
and lactic acid production suggest its potential prebiotic character. 475 
Seaweed extracts, in particular that of O. pinnatifida obtained with Viscozyme, 476 
were fermentable by gut microbiota as indicated by an increase in SCFA. 477 
Increase in SCFA was not always correlated with an increase in bacterial 478 
populations for the seaweed extracts.  479 
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Figure captions 624 
Figure 1. Bacterial populations (a) Bifidobacterium spp.; b) Lactobacillus 625 
spp./Enterococcus spp.; c) Bacteroides group; d) C. cocoides/E. rectale group; e) 626 
C. histolyticum group; f) Total bacteria) analysed by FISH in batch cultures 627 
containing 1% (w/v) of digested extracts of seaweeds O. pinnatifida obtained by 628 
Viscozyme (O.pin_Visc) and S. muticum obtained by Alcalase (S.mut_Alc) and of 629 
mushroom Ph. nameko obtained by Flavourzyme (Ph.nam_Flav) and by Cellulase 630 
(Ph.nam_Cell) and the respective controls. Error bars indicate SD of the replicates 631 
involving 3 adult donors. ap<0.05; significantly different compared to 0h within the 632 
same substrate. *p<0.05; significantly different compared to negative control. 633 
#p<0.05; significantly different compared to FOS, positive control. 634 
 635 
Figure 2. Bacterial populations (a) Bifidobacterium spp.; b) Lactobacillus 636 
spp./Enterococcus spp.; c) Bacteroides group; d) C. cocoides/E. rectale group; e) 637 
C. histolyticum group; f) Total bacteria) analysed by FISH in batch cultures 638 
containing 2 and 3% (w/v) of digested extracts of seaweed O. pinnatifida obtained 639 
  
 
 
by Viscozyme (O.pin_Visc) and of mushroom Ph. nameko obtained by 640 
Flavourzyme (Ph.nam_Flav) and the respective controls. Error bars indicate SD of 641 
the replicates involving 3 adult donors. ap<0.05; significantly different compared to 642 
0h within the same substrate. *p<0.05; significantly different compared to negative 643 
control. #p<0.05; significantly different compared to 2% FOS, positive control.  644 
